Asset Details
Do you wish to reserve the book?
Arterial pathology in canine mucopolysaccharidosis-I and response to therapy
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Arterial pathology in canine mucopolysaccharidosis-I and response to therapy
Do you wish to request the book?
Arterial pathology in canine mucopolysaccharidosis-I and response to therapy
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Arterial pathology in canine mucopolysaccharidosis-I and response to therapy
2011
Overview
Mucopolysaccharidosis-I (MPS-I) is an inherited deficiency of α-L-iduronidase (IdU) that causes lysosomal accumulation of glycosaminoglycans (GAG) in a variety of parenchymal cell types and connective tissues. The fundamental link between genetic mutation and tissue GAG accumulation is clear, but relatively little attention has been given to the morphology or pathogenesis of associated lesions, particularly those affecting the vascular system. The terminal parietal branches of the abdominal aorta were examined from a colony of dogs homozygous (MPS-I affected) or heterozygous (unaffected carrier) for an IdU mutation that eliminated all enzyme activity, and in affected animals treated with human recombinant IdU. High-resolution computed tomography showed that vascular wall thickenings occurred in affected animals near branch points, and associated with low endothelial shear stress. Histologically these asymmetric ‘plaques' entailed extensive intimal thickening with disruption of the internal elastic lamina, occluding more than 50% of the vascular lumen in some cases. Immunohistochemistry was used to show that areas of sclerosis contained foamy (GAG laden) macrophages, fibroblasts and smooth muscle cells, with loss of overlying endothelial basement membrane and claudin-5 expression. Lesions contained scattered cells expressing nuclear factor-κβ (p65), increased fibronectin and transforming growth factor β-1 signaling (with nuclear Smad3 accumulation) in comparison to unaffected vessels. Intimal lesion development and morphology was improved by intravenous recombinant enzyme treatment, particularly with immune tolerance to this exogenous protein. The progressive sclerotic vasculopathy of MPS-I shares some morphological and molecular similarities to atherosclerosis, including formation in areas of low shear stress near branch points, and can be reduced or inhibited by intravenous administration of recombinant IdU.
Publisher
Elsevier Inc,Nature Publishing Group US,Nature Publishing Group
Subject
/ Animals
/ Biological and medical sciences
/ Carbohydrates (enzymatic deficiencies). Glycogenosis
/ Dogs
/ Female
/ Fundamental and applied biological sciences. Psychology
/ Humans
/ Iduronidase - administration & dosage
/ Iduronidase - therapeutic use
/ Investigative techniques, diagnostic techniques (general aspects)
/ Male
/ Medicine
/ Mucopolysaccharidosis I - genetics
/ Mucopolysaccharidosis I - pathology
/ Mucopolysaccharidosis I - therapy
/ Mucopolysaccharidosis I - veterinary
/ Recombinant Proteins - administration & dosage
/ Recombinant Proteins - genetics
/ Recombinant Proteins - therapeutic use
/ Vascular Diseases - genetics
/ Vascular Diseases - pathology
